|
1
|
Lee TK, Chaux A, Karram S, Miyamoto H,
Miller JS, Fajardo DA, Epstein JI and Netto GJ: Papillary
urothelial neoplasm of low malignant potential of the urinary
bladder: clinicopathologic and outcome analysis from a single
academic center. Hum Pathol. 42:1799–1803. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
MacLennan GT, Kirkali Z and Cheng L:
Histologic grading of noninvasive papillary urothelial neoplasms.
Eur Urol. 51:889–898. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chaux A, Karram S, Miller JS, Fajardo DA,
Lee TK, Miyamoto H and Netto GJ: High-grade papillary urothelial
carcinoma of the urinary tract: a clinicopathologic analysis of a
post-World Health Organization/International Society of Urological
Pathology classification cohort from a single academic center. Hum
Pathol. 43:115–120. 2012. View Article : Google Scholar
|
|
4
|
Cheng L, Davidson DD, Maclennan GT,
Williamson SR, Zhang S, Koch MO, Montironi R and Lopez-Beltran A:
The origins of urothelial carcinoma. Expert Rev Anticancer Ther.
10:865–880. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cordon-Cardo C, Cote RJ and Sauter G:
Genetic and molecular markers of urothelial premalignancy and
malignancy. Scand J Urol Nephrol. (Suppl 205): 82–93. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cohen SM: Urinary bladder carcinogenesis.
Toxicol Pathol. 26:121–127. 1998. View Article : Google Scholar
|
|
7
|
Vageli D, Kiaris H, Delakas D, Anezinis P,
Cranidis A and Spandidos DA: Transcriptional activation of H-ras,
K-ras and N-ras proto-oncogenes in human bladder tumors. Cancer
Lett. 107:241–247. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Preston BD, Albertson TM and Herr AJ: DNA
replication fidelity and cancer. Semin Cancer Biol. 20:281–293.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Umar A and Kunkel TA: DNA-replication
fidelity, mismatch repair and genome instability in cancer cells.
Eur J Biochem. 238:297–307. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Marti TM, Kunz C and Fleck O: DNA mismatch
repair and mutation avoidance pathways. J Cell Physiol. 191:28–41.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Acharya S, Wilson T, Gradia S, Kane MF,
Guerrette S, Marsischky GT, Kolodner R and Fishel R: hMSH2 forms
specific mispair-binding complexes with hMSH3 and hMSH6. Proc Natl
Acad Sci USA. 93:13629–13634. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Genschel J, Littman SJ, Drummond JT and
Modrich P: Isolation of MutSbeta from human cells and comparison of
the mismatch repair specificities of MutSbeta and MutSalpha. J Biol
Chem. 273:19895–19901. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Umar A, Risinger JI, Glaab WE, Tindall KR,
Barrett JC and Kunkel TA: Functional overlap in mismatch repair by
human MSH3 and MSH6. Genetics. 148:1637–1646. 1998.PubMed/NCBI
|
|
14
|
Nakagawa T, Datta A and Kolodner RD:
Multiple functions of MutS- and MutL-related heterocomplexes. Proc
Natl Acad Sci USA. 96:14186–14188. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ruszkiewicz A, Bennett G, Moore J, Manavis
J, Rudzki B, Shen L and Suthers G: Correlation of mismatch repair
genes immunohistochemistry and microsatellite instability status in
HNPCC-associated tumours. Pathology. 34:541–547. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vageli D, Daniil Z, Dahabreh J, Karagianni
E, Vamvakopoulou DN, Ioannou MG, Scarpinato K, Vamvakopoulos NC,
Gourgoulianis KI and Koukoulis GK: Phenotypic mismatch repair hMSH2
and hMLH1 gene expression profiles in primary non-small cell lung
carcinomas. Lung Cancer. 64:282–288. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dietmaier W, Wallinger S, Bocker T,
Kullmann F, Fishel R and Rüschoff J: Diagnostic microsatellite
instability: definition and correlation with mismatch repair
protein expression. Cancer Res. 57:4749–4756. 1997.PubMed/NCBI
|
|
18
|
Mylona E, Zarogiannos A, Nomikos A,
Giannopoulou I, Nikolaou I, Zervas A and Nakopoulou L: Prognostic
value of microsatellite instability determined by
immunohistochemical staining of hMSH2 and hMSH6 in urothelial
carcinoma of the bladder. APMIS. 116:59–65. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamamoto Y, Matsuyama H, Kawauchi S,
Furuya T, Liu XP, Ikemoto K, Oga A, Naito K and Sasaki K:
Biological characteristics in bladder cancer depend on the type of
genetic instability. Clin Cancer Res. 12:2752–2758. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Catto JW, Xinarianos G, Burton JL, Meuth M
and Hamdy FC: Differential expression of hMLH1 and hMSH2 is related
to bladder cancer grade, stage and prognosis but not microsatellite
instability. Int J Cancer. 105:484–490. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rubio J, Blanes A, Sanchez-Carrillo JJ and
Diaz-Cano SJ: Microsatellite abnormalities and somatic
down-regulation of mismatch repair characterize nodular-trabecular
muscle-invasive urothelial carcinoma of the bladder.
Histopathology. 51:458–467. 2007. View Article : Google Scholar
|
|
22
|
Ericson KM, Isinger AP, Isfoss BL and
Nilbert MC: Low frequency of defective mismatch repair in a
population-based series of upper urothelial carcinoma. BMC Cancer.
5:232005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Saetta AA, Goudopoulou A, Korkolopoulou P,
Voutsinas G, Thomas-Tsagli E, Michalopoulos NV and Patsouris E:
Mononucleotide markers of microsatellite instability in carcinomas
of the urinary bladder. Eur J Surg Oncol. 30:796–803. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kassem HS, Varley JM, Hamam SM and
Margison GP: Immunohistochemical analysis of expression and
allelotype of mismatch repair genes (hMLH1 and hMSH2) in bladder
cancer. Br J Cancer. 84:321–328. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thykjaer T, Christensen M, Clark AB,
Hansen LR, Kunkel TA and Ørntoft TF: Functional analysis of the
mismatch repair system in bladder cancer. Br J Cancer. 85:568–575.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Leach FS, Hsieh JT, Molberg K, Saboorian
MH, McConnell JD and Sagalowsky AI: Expression of the human
mismatch repair gene hMSH2: a potential marker for urothelial
malignancy. Cancer. 88:2333–2341. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vageli D, Ioannou MG and Koukoulis GK:
Transcriptional activation of hTERT in breast carcinomas by the
Her2-ER81-related pathway. Oncol Res. 17:413–423. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang YC, Lu YP, Tseng RC, Lin RK, Chang
JW, Chen JT, Shih CM and Chen CY: Inactivation of hMLH1 and hMSH2
by promoter methylation in primary non-small cell lung tumors and
matched sputum samples. J Clin Invest. 111:887–895. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou XP, Hoang JM, Cottu P, Thomas G and
Hamelin R: Allelic profiles of mononucleotide repeat
microsatellites in control individuals and in colorectal tumors
with and without replication errors. Oncogene. 15:1713–1718. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hoang JM, Cottu PH, Thuille B, Salmon RJ,
Thomas G and Hamelin R: BAT-26, an indicator of the replication
error phenotype in colorectal cancers and cell lines. Cancer Res.
57:300–303. 1997.PubMed/NCBI
|
|
31
|
Vageli D, Daniil Z, Dahabreh J, Karagianni
E, Liloglou T, Koukoulis G and Gourgoulianis K: Microsatellite
instability and loss of heterozygosity at the MEN1 locus in lung
carcinoid tumors: a novel approach using real-time PCR with melting
curve analysis in histopathologic material. Oncol Rep. 15:557–564.
2006.
|
|
32
|
Ericson KM, Isinger AP, Isfoss BL and
Nilbert MC: Low frequency of defective mismatch repair in a
population-based series of upper urothelial carcinoma. BMC Cancer.
5:232005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shcherbakova PV, Hall MC, Lewis MS,
Bennett SE, Martin KJ, Bushel PR, Afshari CA and Kunkel TA:
Inactivation of DNA mismatch repair by increased expression of
yeast MLH1. Mol Cell Biol. 21:940–951. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mao G, Lee S, Ortega J, Gu L and Li GM:
Modulation of microRNA processing by mismatch repair protein MutLα.
Cell Res. 22:973–985. 2012.PubMed/NCBI
|
|
35
|
Chang DK, Ricciardiello L, Goel A, Chang
CL and Boland CR: Steady-state regulation of the human DNA mismatch
repair system. J Biol Chem. 275:18424–18431. 2000. View Article : Google Scholar
|
|
36
|
Köster F, Schröer A, Fischer D,
Greweldinger T, Diedrich K and Friedrich M: Correlation of DNA
mismatch repair protein hMSH2 immunohistochemistry with p53 and
apoptosis in cervical carcinoma. Anticancer Res. 27:63–68.
2007.PubMed/NCBI
|
|
37
|
Hayes AP, Sevi LA, Feldt MC, Rose MD and
Gammie AE: Reciprocal regulation of nuclear import of the yeast
MutSalpha DNA mismatch repair proteins Msh2 and Msh6. DNA Repair
(Amst). 8:739–751. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bonnal C, Ravery V, Toublanc M, Bertrand
G, Boccon-Gibod L, Henin D, et al: Absence of microsatellite
instability in transitional cell carcinoma of the bladder. Urology.
55:287–291. 2000. View Article : Google Scholar : PubMed/NCBI
|
